•
Jun 30, 2022

Quanterix Q2 2022 Earnings Report

Quanterix announced operating results and a business re-alignment plan, and it revised its 2022 guidance.

Key Takeaways

Quanterix reported that second quarter revenues were impacted by a reduction in consumable revenue due to assay quality challenges and process improvement initiatives. The company is implementing a strategic business re-alignment plan, including a workforce reduction of approximately 130 employees, to improve its cost structure and focus on key platforms.

Second quarter revenues were impacted by a reduction in consumable revenue due to assay quality challenges.

The company announced a strategic business re-alignment plan, including restructuring.

The plan includes an assay redevelopment program to improve the ability to manufacture and deliver high-quality assays at scale.

The company expects to incur restructuring and related charges of approximately $7 million to $10 million in Q3 2022 and realize run-rate savings of approximately $25 million on an annualized basis.

Total Revenue
$23.5M
Previous year: $25.4M
-7.4%
EPS
-$0.67
Previous year: -$0.33
+103.0%
Gross Profit
$8.64M
Previous year: $12.9M
-33.2%
Cash and Equivalents
$362M
Previous year: $431M
-16.1%
Free Cash Flow
-$13M
Previous year: -$17M
-23.6%
Total Assets
$489M
Previous year: $528M
-7.5%

Quanterix

Quanterix

Forward Guidance

Quanterix now expects its total 2022 revenue to be flat compared to 2021 and expects to return to double digit revenue growth by 2024.